Analystreport

Bellerophon Therapeutics Inc (NASDAQ: BLPH) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

Bellerophon Therapeutics, Inc.  (BLPH) 
Last bellerophon therapeutics, inc. earnings: 4/6 10:23 am Check Earnings Report
US:NASDAQ Investor Relations: investors.bellerophon.com